News – Ypsomed Delivery Systems

The topping-out ceremony for Ypsomed's new production plant took place on 28 June 2018. The Swiss medical technology company is building a new production plant in Schwerin's industrial park, creating around 150 new jobs in the region in the coming years. The new production plant will start operations in summer 2019.

News – Ypsomed Delivery Systems

Ypsomed is looking forward to exhibiting at BIO International Convention 2018 in Boston, Massachusetts from June 4-7.

News – Ypsomed Delivery Systems

The latest issue of Medical Devices: Evidence and Research presents a formative usability study for FixPen, a fixed-dose pen-injector platform device, used primarily for patient self-injection.

News – Ypsomed Delivery Systems

Tune in at the Drug/Device Combination Products Summit in Vienna.

News – Ypsomed Delivery Systems

Listen to us at the PharmaEd pre-filled syringes Meeting in Philadelphia.

News – Ypsomed Delivery Systems

Ypsomed to present “Injection Devices for Biosimilars” at the Biotech Pharma Summit 2018 in Porto.

New article published in ONdrugDELIVERY

News – Ypsomed Delivery Systems

This article provides insights into the development of platform products that offer pharma companies low risks and shorter timelines at an attractive cost.

News – Ypsomed Delivery Systems

Ypsomed Delivery Systems is showcasing its complete range of self-injection devices at the upcoming Pharmapack Europe.

Past research has emphasized injection force as a clinically highly relevant technical attribute of pen devices. However, little work has been conducted to relate these results to in-use studies.

California, USA, 7-8 December 2017

News – Ypsomed Delivery Systems

Jakob Lange, Key Account Director Delivery Systems, will give a presentation about the trends in self-injection: Large volume autoinjectors, wearable devices and connectivity in self-injection.